Navigation Links
Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
Date:9/24/2007

n subgroups of patients treated with Cethrin are analyzed, patients with cervical injuries exhibit a more pronounced response compared to patients with thoracic injuries, showing a conversion rate that is six to seven times greater than the full patient group treated with the standard of care reported in the publication above. In patients with cervical injuries, the interim efficacy data also suggest that the response rate observed is dose dependent at the doses tested to date.

About Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE) is a biotechnology company engaged in developing breakthrough regenerative therapeutics to treat traumatic injuries and degenerative diseases. The Company maintains a world- class intellectual property position in the field of regenerative therapeutics. Our energy and focus is reflected in several important initiatives. Cethrin(R), a recombinant-protein-based drug designed to promote nerve repair after acute spinal cord injury, demonstrated positive interim results in a Phase I/IIa clinical trial. The Company's research and pre- clinical programs include, Inosine for the treatment of spinal cord injury and stroke, Oncomodulin for the treatment of ocular injury and disease and research programs directed at a number of regenerative therapies including bone repair. The company has a robust molecular imaging development program targeting diagnosis of Parkinson's disease and potentially dementia and ADHD. Our lead product candidate is ALTROPANE(R) which is in Phase III clinical trials for the diagnosis of Parkinson's disease. Alseres has research collaborations with Harvard Medical School and Children's Hospital Boston.

Safe harbor

The foregoing release
'/>"/>

SOURCE Alseres Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/bsfm2s/cardiovascular ) has ... "Cardiovascular Drug Delivery - Technologies, Markets and Companies" ... to the cardiovascular system is different from delivery to ... the vascular system; it supplies blood and nutrients to ... into the vascular system for systemic effects or targeted ...
(Date:3/3/2015)... , March 3, 2015  Cardinal Health has been ... for Executive Women " by the National Association for ... and promote successful women. "We,re counting ... top companies and are happy to find that companies ... Spence , NAFE President. "The 2015 NAFE Top Companies ...
(Date:3/3/2015)... , March 3, 2015  HeartIT is ... the first Cardiac Magnetic Resonance Solution in the ... within a standard web browser. Precession™ combines zero ... features unmatched in the industry. This provides CMR ... all the critical functions of a successful CMR ...
Breaking Medicine Technology:Global Cardiovascular Drug Delivery Technologies, Markets and Companies 2014-2024 2Global Cardiovascular Drug Delivery Technologies, Markets and Companies 2014-2024 3Cardinal Health Named One of the "Top 50 Companies for Executive Women" by NAFE 2Cardinal Health Named One of the "Top 50 Companies for Executive Women" by NAFE 3Cardinal Health Named One of the "Top 50 Companies for Executive Women" by NAFE 4Precession Advances Medical Imaging by Delivering a Complete Cardiac Magnetic Resonance Platform in a Web Browser 2
... Palomar Medical Technologies, Inc. (Nasdaq: PMTI ), ... treatments, will hold its quarterly conference call of its 2011 ... 11:30AM Eastern Time. If you would like to participate, please ... day. A live webcast of Palomar,s conference call ...
... a leading manufacturer of critical care products, celebrates their ... website. In the last four years, Novis has experienced ... (RXID), customer focus, service excellence and superior compliance programs. ... our customers with outstanding service. We have a really ...
Cached Medicine Technology:Palomar Medical Technologies to Host First Quarter 2011 Financial Results Conference Call and Webcast on April 28, 2011 2Palomar Medical Technologies to Host First Quarter 2011 Financial Results Conference Call and Webcast on April 28, 2011 3Novis Pharmaceuticals Celebrates Four Years With New Website Launch 2
(Date:3/3/2015)... Fla - (March 3, 2015) (PRWEB) March 03, 2015 ... Vacations, Inc. (FCV), an innovator in the travel industry ... in his trailblazing expansion plan. To fulfill his vision ... the addition of 400 fun, exciting and well-compensated positions ... headquarters and a news sales center planned for the ...
(Date:3/3/2015)... 03, 2015 OncLive® and Indiana ... joined forces to share news about the center’s ... collaboration is part of OncLive’s Strategic Alliance Partnership ... editorial and marketing teams will partner with the ... cancer center, to highlight accomplishments. They include the ...
(Date:3/3/2015)... The FSH Society , the Massachusetts-based ... and incurable disease, facioscapulohumeral muscular dystrophy (FSHD), today announced ... purpose of the campaign is to spread awareness and ... forms of muscular dystrophies. , To begin the ... Society will begin sharing impactful photographs of people with ...
(Date:3/3/2015)... March 03, 2015 Presale tickets for Madonna ... the general public begin on March 9, with Madonna tour ... Every tour performed by the talented artist is a significant ... no exception. , Visit Ticketability.com to browse the ... new album for fans to enjoy, the 2015 tour is ...
(Date:3/3/2015)... State after state prove the cost ... programs aimed to rehabilitate nonviolent drug offenders. The ... of incarcerating violators of drug laws, as opposed ... treatment. Governor Bruce Rauner ( R)has proposed to ... and alcohol statewide Department of Alcoholism and Substance ...
Breaking Medicine News(10 mins):Health News:First Class Vacations, Inc. Expansion Plan Creates 400 Jobs In South Florida 2Health News:First Class Vacations, Inc. Expansion Plan Creates 400 Jobs In South Florida 3Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 2Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 3Health News:Share to be Aware: FSH Society Launches #CureFSHD Campaign 2Health News:Share to be Aware: FSH Society Launches #CureFSHD Campaign 3Health News:Presale Tickets for Madonna: Ticketability.com Announces Madonna Tour Tickets for Sale at Reduced Prices for the Rebel Heart Tour During Presales 2Health News:Gov. of Illinois, Bruce Rauner, Suggests Cutting 25 Million for Drug Rehabilitation, Harbor Village Comments 2
... Conference on Cell Therapy for Cardiovascular Disease (IC3D) is ... field of cell-based therapies for the repair and regeneration ... diseases such as diabetes and stroke. This year,s conference ... the status of molecular, cell, and tissue products in ...
... Nov. 30 (HealthDay News) -- Despite calls by some experts that ... the Institute of Medicine finds that most people are getting enough ... up the recommended dietary allowance of vitamin D from the amount ... For many people, 600 international units (IUs) of vitamin D or ...
... Reinberg HealthDay Reporter , TUESDAY, Nov. 30 (HealthDay ... a record high, but more than 200,000 Americans are infected ... finds. "The numbers show that progress is possible; they ... R. Frieden, director of the U.S. Centers for Disease Control ...
... American Society of Hematology (ASH) will host its ... Center in Orlando, FL, December 4-7. More than 20,000 ... emerging research trends in the diagnosis, treatment, and understanding ... to host the 2010 ASH annual meeting, which provides ...
... 30, 2010 The latest episode in the American ... Solutions ," focuses on the discovery that black rice ... the staple food for one-third of the world,s population ... asthma and other diseases. In the podcast, ...
... Nov. 29 (HealthDay News) -- Children who eat a diet rich ... atherosclerosis in adulthood, a precursor of heart disease, a new study ... young as 9 years old may already be exhibiting health problems ... heart disease as adults. Both reports, from researchers in Finland, ...
Cached Medicine News:Health News:Sixth global conference on stem cell therapy to be held Jan. 20-21, 2011, in New York City 2Health News:Vitamin D Guidelines Edge Upwards, But Most Americans Getting Enough: Report 2Health News:Vitamin D Guidelines Edge Upwards, But Most Americans Getting Enough: Report 3Health News:Vitamin D Guidelines Edge Upwards, But Most Americans Getting Enough: Report 4Health News:Record Number of Americans Tested for HIV 2Health News:ASH's 52nd Annual Meeting and Exposition showcases the latest advances in the field 2Health News:ASH's 52nd Annual Meeting and Exposition showcases the latest advances in the field 3Health News:Kids Who Eat Fruits, Veggies May Cut Heart Risk 2Health News:Kids Who Eat Fruits, Veggies May Cut Heart Risk 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: